金达威控股子公司取得兽药产品批准文号批件

Core Viewpoint - The company, Jindawei (002626.SZ), announced that its subsidiary, Jiangsu Chengxin Pharmaceutical Co., Ltd., has received a veterinary drug approval from the Ministry of Agriculture and Rural Affairs of the People's Republic of China for the product Pyrantel, with the approval number 102091173 [1] Group 1 - The approval signifies a regulatory milestone for the company in the veterinary pharmaceutical sector [1] - The product Pyrantel is expected to enhance the company's product portfolio and market presence in the veterinary medicine industry [1]